cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.14814913.v2
title: The Role of testosterone treatment in patients with metabolic disorders

description: The specific role of testosterone [T] replacement therapy [TRT] on glycometabolic profile and body composition, particularly in patients with metabolic syndrome [MetS] and/or type 2 diabetes mellitus [T2DM], is still the object of an intense debate. To discuss available evidence on the association between T and metabolic diseases and on the possible effect of T administration on metabolic disorder-associated hypogonadism. Both preclinical and clinical data have been considered. In addition, a meta-analysis of the available placebo and non-placebo-controlled randomized clinical trials [RCTs] investigating the effects of TRT in T2DM or MetS in several outcomes has been also performed. Data derived from preclinical and clinical studies suggest that T administration, by reducing fat mass, can improve body composition and ameliorate some aspects of glucose metabolism. The effects of TRT on sexual function in patients with established metabolic derangements are inconsistent, whereas better results were observed in preclinical conditions or in patients with newly diagnosed T2DM.
DOI: 10.6084/m9.figshare.14814913.v1
title: The Role of testosterone treatment in patients with metabolic disorders

description: The specific role of testosterone [T] replacement therapy [TRT] on glycometabolic profile and body composition, particularly in patients with metabolic syndrome [MetS] and/or type 2 diabetes mellitus [T2DM], is still the object of an intense debate. To discuss available evidence on the association between T and metabolic diseases and on the possible effect of T administration on metabolic disorder-associated hypogonadism. Both preclinical and clinical data have been considered. In addition, a meta-analysis of the available placebo and non-placebo-controlled randomized clinical trials [RCTs] investigating the effects of TRT in T2DM or MetS in several outcomes has been also performed. Data derived from preclinical and clinical studies suggest that T administration, by reducing fat mass, can improve body composition and ameliorate some aspects of glucose metabolism. The effects of TRT on sexual function in patients with established metabolic derangements are inconsistent, whereas better results were observed in preclinical conditions or in patients with newly diagnosed T2DM.
DOI: 10.6084/m9.figshare.16586534
title: Cleaned spectral dataset in single .rds file

description: This file contains all spectra used in Stasinski et al. Any measurement with reflectance greater than 1 was removed from this dataset, and all spectra were trimmed to a range of 400 to 2400 nm to remove regions of excess noise. Metadata are also attached to these spectra.
DOI: 10.5281/zenodo.5494733
title: AnnaMankowski_PhDthesis_ExtendedData_ChapterIII

description: Extended Data supporting the results and analyses that are presented in Chapter III of my PhD thesis.
DOI: 10.5281/zenodo.5494732
title: AnnaMankowski_PhDthesis_ExtendedData_ChapterIII

description: Extended Data supporting the results and analyses that are presented in Chapter III of my PhD thesis.
DOI: 10.6084/m9.figshare.13551392
title: Dryas reflectance spectra from two Wickersham Dome locations

description: Leaf reflectance spectra from Dryas ajanensis, Dryas alaskensis, and their hybrids from Eagle Summit. Refer to wda_pops.csv and wdb_pops.csv for metadata.
DOI: 10.5281/zenodo.5105687
title: Model output from Inverting ice surface elevation and velocity for bed topography and slipperiness beneath Thwaites Glacier

description: This model output dataset accompanies the draft paper 'Inverting ice surface elevation and velocity for bed topography and slipperiness beneath Thwaites Glacier'.
DOI: 10.5281/zenodo.5105686
title: Model output from Inverting ice surface elevation and velocity for bed topography and slipperiness beneath Thwaites Glacier

description: This model output dataset accompanies the draft paper 'Inverting ice surface elevation and velocity for bed topography and slipperiness beneath Thwaites Glacier'.
DOI: 10.6084/m9.figshare.13551377
title: Dryas reflectance spectra from Murphy Dome

description: Leaf reflectance spectra from Dryas ajanensis, Dryas alaskensis, and their hybrids from Eagle Summit. Refer to mdb_pops.csv for metadata.
DOI: 10.6084/m9.figshare.13551371
title: Dryas leaf reflectance data from Eagle Summit

description: Leaf reflectance spectra from Dryas ajanensis, Dryas alaskensis, and their hybrids from Eagle Summit. Refer to es_pops.csv for metadata.
DOI: 10.6084/m9.figshare.13551371.v1
title: Dryas leaf reflectance data from Eagle Summit

description: Leaf reflectance spectra from Dryas octopetala, Dryas alaskensis, and their hybrids from Eagle Summit.
DOI: 10.5281/zenodo.5494735
title: Prevalence of oral mucosal lesions in edentulous patients at a tertiary dental teaching hospital

description: A retrospective records-based study design was conducted in student dental clinics at Tygerberg Oral Health Centre, University of the Western Cape. Information was collected from patient files who received complete dentures in the period 2014-2019. Data collected included the patient's age, gender, medical conditions, denture experience, presence of oral candidiasis, site of lesion and treatment for the condition. Patients were further classified using the Uniform Patient Fee Schedule (UPFS). Patients treated in government hospitals are charged according to the UPFS, which sets a tariff according to the level of hospital providing the treatment, category of medical staff providing the treatment and the income of the patient.A retrospective records-based study design was conducted in student dental clinics at Tygerberg Oral Health Centre, University of the Western Cape. Information was collected from patient files who received complete dentures in the period 2014-2019. Data collected included the patient's age, gender, medical conditions, denture experience, presence of oral candidiasis, site of lesion and treatment for the condition. Patients were further classified using the Uniform Patient Fee Schedule (UPFS). Patients treated in government hospitals are charged according to the UPFS, which sets a tariff according to the level of hospital providing the treatment, category of medical staff providing the treatment and the income of the patient.
DOI: 10.5281/zenodo.5494734
title: Prevalence of oral mucosal lesions in edentulous patients at a tertiary dental teaching hospital

description: A retrospective records-based study design was conducted in student dental clinics at Tygerberg Oral Health Centre, University of the Western Cape. Information was collected from patient files who received complete dentures in the period 2014-2019. Data collected included the patient's age, gender, medical conditions, denture experience, presence of oral candidiasis, site of lesion and treatment for the condition. Patients were further classified using the Uniform Patient Fee Schedule (UPFS). Patients treated in government hospitals are charged according to the UPFS, which sets a tariff according to the level of hospital providing the treatment, category of medical staff providing the treatment and the income of the patient.A retrospective records-based study design was conducted in student dental clinics at Tygerberg Oral Health Centre, University of the Western Cape. Information was collected from patient files who received complete dentures in the period 2014-2019. Data collected included the patient's age, gender, medical conditions, denture experience, presence of oral candidiasis, site of lesion and treatment for the condition. Patients were further classified using the Uniform Patient Fee Schedule (UPFS). Patients treated in government hospitals are charged according to the UPFS, which sets a tariff according to the level of hospital providing the treatment, category of medical staff providing the treatment and the income of the patient.
DOI: 10.34740/kaggle/dsv/2597226
title: 2021 World Population (updated daily)
DOI: 10.6084/m9.figshare.13551362
title: Dryas Spectra from Bison Gulch and Twelve Mile Summit

description: Reflectance data from dry leaves of Dryas ajanensis, Dryas alaskensis, and their hybrids. Data from two locations: Bison Gulch and Twelve Mile Summit. See tm_pops.csv and bg_pops.csv for metadata.
DOI: 10.21942/uva.16586663.v1
title: strucure CPD

description: molcular structure<br>
DOI: 10.6084/m9.figshare.14622093.v1
title: Contamination effects on the biota of Brazilian coastal ecosystems: Scientific challenges for a developing country in a changing world

description: This dataset is from a review on the knowledge status of contamination and effects of contaminants on the biota of Brazilian coastal ecosystems. The spreadsheet contains the list of reviewed publications and the information extracted from each publication<br>
DOI: 10.5281/zenodo.5494737
title: Dataset related to the article "Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study"

description: <em>The file contains raw data related to the article "Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study", available from https://onlinelibrary.wiley.com/doi/10.1002/pds.5159.</em> <strong>Abstract of the manuscript:</strong> <strong>Purpose: </strong>We examined data collected in the Monzino 80-plus study to assess the relations between cognitive performance and ACB scores according to the hypothesis that a higher anticholinergic burden is associated with reduced cognitive performance. <strong>Methods: </strong>The Monzino 80-plus is an ongoing, prospective, door-to-door population-based study started in 2002 among all residents 80 years or older in eight municipalities of Varese province, Italy. To establish the relation between cognitive impairment and the anticholinergic drug burden we recorded the ACB score for each patient at baseline. The relations between ACB score and dementia or MMSE scores were also examined after exclusion of patients taking any antipsychotic. <strong>Results: </strong>A sample of 2140 elderly people was eligible for analysis. A significant dose-effect relationship was observed between total ACB score and diagnosis of dementia in univariate and multivariate models. Patients in ACB class ≥4 had about 4.5 times the risk of diagnosis of dementia. A relation was also found between higher ACB scores and lower MMSE scores; patients who scored 4 or more had a mean of 6.4 points lower than those not taking anticholinergic drugs. The dose-effect relationship between ACB score and diagnosis of dementia was not maintained after exclusion of patients using antipsychotics, while the association between higher ACB scores and lower MMSE scores was still present, with patients in ACB class ≥4 having a mean score about 4.4 lower. <strong>Conclusions: </strong>There are clear relations between anticholinergic load and reduced cognitive performance, while the association with dementia remains uncertain. For primary care and geriatric clinicians, an ACB score ≥ 4 can be considered the cut-off to identify high-risk populations who may benefit from the evaluation of anticholinergic burden with the ACB scale.
description: {"references": ["Pasina L, Lucca U, Tettamanti M. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study. Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1696-1702. doi: 10.1002/pds.5159. Epub 2020 Nov 3. PMID: 33098318."]}
DOI: 10.5281/zenodo.5494736
title: Dataset related to the article "Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study"

description: <em>The file contains raw data related to the article "Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study", available from https://onlinelibrary.wiley.com/doi/10.1002/pds.5159.</em> <strong>Abstract of the manuscript:</strong> <strong>Purpose: </strong>We examined data collected in the Monzino 80-plus study to assess the relations between cognitive performance and ACB scores according to the hypothesis that a higher anticholinergic burden is associated with reduced cognitive performance. <strong>Methods: </strong>The Monzino 80-plus is an ongoing, prospective, door-to-door population-based study started in 2002 among all residents 80 years or older in eight municipalities of Varese province, Italy. To establish the relation between cognitive impairment and the anticholinergic drug burden we recorded the ACB score for each patient at baseline. The relations between ACB score and dementia or MMSE scores were also examined after exclusion of patients taking any antipsychotic. <strong>Results: </strong>A sample of 2140 elderly people was eligible for analysis. A significant dose-effect relationship was observed between total ACB score and diagnosis of dementia in univariate and multivariate models. Patients in ACB class ≥4 had about 4.5 times the risk of diagnosis of dementia. A relation was also found between higher ACB scores and lower MMSE scores; patients who scored 4 or more had a mean of 6.4 points lower than those not taking anticholinergic drugs. The dose-effect relationship between ACB score and diagnosis of dementia was not maintained after exclusion of patients using antipsychotics, while the association between higher ACB scores and lower MMSE scores was still present, with patients in ACB class ≥4 having a mean score about 4.4 lower. <strong>Conclusions: </strong>There are clear relations between anticholinergic load and reduced cognitive performance, while the association with dementia remains uncertain. For primary care and geriatric clinicians, an ACB score ≥ 4 can be considered the cut-off to identify high-risk populations who may benefit from the evaluation of anticholinergic burden with the ACB scale.
description: {"references": ["Pasina L, Lucca U, Tettamanti M. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study. Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1696-1702. doi: 10.1002/pds.5159. Epub 2020 Nov 3. PMID: 33098318."]}
DOI: 10.6084/m9.figshare.14261489
title: FOB microscopy - HeLa P525L GFP-FUS

description: Fluorescence, optical diffraction tomography and Brillouin microscopy data of HeLa P525L GFP-FUS cells under control conditions, after arsenite treatment, and after arsenite treatment and chemical fixation.<br>
DOI: 10.6084/m9.figshare.14261489.v2
title: FOB microscopy - HeLa P525L GFP-FUS

description: Fluorescence, optical diffraction tomography and Brillouin microscopy data of HeLa P525L GFP-FUS cells under control conditions, after arsenite treatment, and after arsenite treatment and chemical fixation.<br>
DOI: 10.6084/m9.figshare.14261489.v1
title: FOB microscopy - HeLa P525L GFP-FUS

description: Fluorescence, optical diffraction tomography and Brillouin microscopy data of HeLa P525L GFP-FUS cells with and without arsenite treatment.
DOI: 10.5281/zenodo.5494612
title: Xyliphius kryptos SPAdes preassembly

description: .
DOI: 10.5281/zenodo.5494611
title: Xyliphius kryptos SPAdes preassembly

description: .
DOI: 10.6084/m9.figshare.16573673
title: Supplementary Information

description: <b>Supplementary Information 1:</b> Size distribution and concentration of nanoparticles in cell-free supernatants of exponential and stationary phase Pbr1692 cultures.<br><b>Supplementary Information 2:</b><br>Pbr1692 OMV associated proteins.
DOI: 10.6084/m9.figshare.16573673.v2
title: Supplementary Information

description: <b>Supplementary Information 1:</b> Size distribution and concentration of nanoparticles in cell-free supernatants of exponential and stationary phase Pbr1692 cultures.<br><b>Supplementary Information 2:</b><br>Pbr1692 OMV associated proteins.
DOI: 10.6084/m9.figshare.16573673.v1
title: Supplementary Information

description: <b>Supplementary Information 1:</b> Size distribution and concentration of nanoparticles in cell-free supernatants of exponential and stationary phase Pbr1692 cultures.<br><b>Supplementary Information 2:</b><br>Pbr1692 OMV associated proteins.
DOI: 10.34740/kaggle/dsv/2597253
title: YouTube Trending Video Dataset (updated daily)
DOI: 10.6084/m9.figshare.16557455.v1
title: Python Codes from Honesty and dishonesty in gossip strategies: a fitness interdependence analysis

description: Python codes for generating figures from models
DOI: 10.6084/m9.figshare.16557455
title: Python Codes from Honesty and dishonesty in gossip strategies: a fitness interdependence analysis

description: Python codes for generating figures from models
DOI: 10.21942/uva.16586663.v2
title: structure CPD

description: molcular structure<br>
DOI: 10.6084/m9.figshare.14622093.v2
title: Dataset of the paper "Reviewing the effects of contamination effects on the biota of Brazilian coastal ecosystems: Scientific challenges for a developing country in a changing world"

description: This dataset is from a review on the knowledge status of contamination and effects of contaminants on the biota of Brazilian coastal ecosystems. The spreadsheet contains the list of reviewed publications and the information extracted from each publication<br>
DOI: 10.6084/m9.figshare.16586690
title: Supplementary Material for: Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?

description: <b><i>Introduction:</i></b> The need for noninvasive markers of disease activity is mandatory in the assessment of Crohn’s disease (CD). The most widely fecal biomarker in CD, despite several limits, is fecal calprotectin. This review aims to elucidate the role, if any, of all other fecal biomarkers, as alternative tools for assessing clinical and endoscopic disease activity, and predict capsule endoscopy findings, response to therapy, disease relapse, and postoperative recurrence. These fecal biomarkers included lactoferrin, S100A12, high mobility group box 1, neopterin, polymorphonuclear neutrophil elastase, fecal hemoglobin, alpha1-antitrypsin, lysozyme, human beta-defensin-2, neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, chitinase 3-like-1, M2-pyruvate kinase, myeloperoxidase, and eosinophil proteins. <b><i>Methods:</i></b> A systematic electronic search in the medical literature was performed up to April 2020. Seventy eligible studies were identified out of 859 citations. Data were grouped according to the assessment of clinical and endoscopic disease activity, capsule endoscopy findings, response to therapy, prediction of relapse, and postoperative recurrence. <b><i>Results:</i></b> The overall correlation between lactoferrin and clinical indexes is poor, while performance is good with endoscopic scores. Lactoferrin seems to represent a reasonably good surrogate marker of response to therapy and to be potentially useful in identifying patients at high risk for endoscopic relapse or postoperative recurrence. The evaluation of the performance of all other fecal markers is limited by the lack of adequate data. <b><i>Conclusions:</i></b> None of the fecal markers so far represents an acceptable alternative to calprotectin in clinical practice. Fecal lactoferrin is the only possible exception, but a more extensive investigation is still required.
DOI: 10.5281/zenodo.3981198
title: Map of growing stock volume of Russian forests for the year 2014

description: The data products consist of two layers that include estimates of<br> 1. growing stock volume (GSV, unit: m3/ha) for the year 2014 (raster data set)<br> Definition: volume of all living trees more than 6 cm in diameter at breast height measured over bark from ground to a top stem diameter of 0 cm. Excludes: branches, twigs, foliage, flowers, seeds, stump and roots.<br> 2. per-pixel of growing stock volume uncertainty expressed as standard error in m3/ha (raster data set) The maps have a spatial resolution of 3.2 arc sec (ca 0.5 ha for Russia). The GSV estimates were obtained by calibration of two remote sensing-based maps with ca 8000 ground plots from the National Forest Inventory:<br> • The global GlobBiomass map of GSV (Santoro, 2018; Santoro et al., 2020) is based on synthetic aperture radar (SAR) observations acquired around the year 2010 and has a spatial resolution of 100m, units m³ ha<sup>-1</sup>.<br> • The global Climate Change Initiative (CCI) Biomass map of AGB (Santoro and Cartus, 2019) is also based on SAR data, acquired in 2017 and has a spatial resolution of 100m, units t ha<sup>-1</sup>. The methodology, input data and software are published here: Schepaschenko, D., Moltchanova, E., Fedorov, S. <em>et al.</em> Russian forest sequesters substantially more carbon than previously reported. <em>Sci Rep</em> <strong>11, </strong>12825 (2021). https://doi.org/10.1038/s41598-021-92152-9
description: {"references": ["Santoro, M., 2018. GlobBiomass - global datasets of forest biomass. https://doi.org/10.1594/PANGAEA.894711", "Santoro, M., Cartus, O., 2019. ESA Biomass Climate Change Initiative (Biomass_cci): Global datasets of forest above-ground biomass for the year 2017, v1. https://doi.org/10.5285/BEDC59F37C9545C981A839EB552E4084", "Santoro, M., Cartus, O., Carvalhais, N., et al. 2020. The global forest above-ground biomass pool for 2010 estimated from high-resolution satellite observations. Earth Syst. Sci. Data Discuss. 1\u201338. https://doi.org/10.5194/essd-2020-148"]}
DOI: 10.6084/m9.figshare.16586690.v1
title: Supplementary Material for: Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?

description: <b><i>Introduction:</i></b> The need for noninvasive markers of disease activity is mandatory in the assessment of Crohn’s disease (CD). The most widely fecal biomarker in CD, despite several limits, is fecal calprotectin. This review aims to elucidate the role, if any, of all other fecal biomarkers, as alternative tools for assessing clinical and endoscopic disease activity, and predict capsule endoscopy findings, response to therapy, disease relapse, and postoperative recurrence. These fecal biomarkers included lactoferrin, S100A12, high mobility group box 1, neopterin, polymorphonuclear neutrophil elastase, fecal hemoglobin, alpha1-antitrypsin, lysozyme, human beta-defensin-2, neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, chitinase 3-like-1, M2-pyruvate kinase, myeloperoxidase, and eosinophil proteins. <b><i>Methods:</i></b> A systematic electronic search in the medical literature was performed up to April 2020. Seventy eligible studies were identified out of 859 citations. Data were grouped according to the assessment of clinical and endoscopic disease activity, capsule endoscopy findings, response to therapy, prediction of relapse, and postoperative recurrence. <b><i>Results:</i></b> The overall correlation between lactoferrin and clinical indexes is poor, while performance is good with endoscopic scores. Lactoferrin seems to represent a reasonably good surrogate marker of response to therapy and to be potentially useful in identifying patients at high risk for endoscopic relapse or postoperative recurrence. The evaluation of the performance of all other fecal markers is limited by the lack of adequate data. <b><i>Conclusions:</i></b> None of the fecal markers so far represents an acceptable alternative to calprotectin in clinical practice. Fecal lactoferrin is the only possible exception, but a more extensive investigation is still required.